FDA Approves First Marijuana-Based Prescription Drug Epidiolex is a liquid drug based from cannabidiol or CBD and is used to treat severe forms of epilepsy. CBD does not contain THC, which gives recreational marijuana smokers the feeling of being “high.” The drug was approved on Monday and has been shown to reduce seizures in patients with Lennox-Gastaut Syndrome and Dravet Syndrome. FDA Commissioner
Scott Gottlieb Scott Gottlieb, FDA Commissioner, via NBC News Scott Gottlieb, FDA Commissioner, via NBC News Epidiolex will be rescheduled within 90 days from its current Schedule I status before it can be made available to patients.
